Özet:

The gradual increase in health expenditure each year highlights the importance of cost-controlled inpatient prospective payment systems in health financing in Turkey and around the world. Being in current use in many developed countries, the Diagnosis-related Groups (DRG) model is an effective inpatient prospective payment systemused in healthcare institutions with a high case mix index. The present study aims to determine the efficacy of the DRG inpatient prospective payment system model in the funding of cardiovascular diseases, and to reveal the differences between the CHP-basedand DRG-based pricing models. Findings of the present study reveal that DRG pricing changes while CHP pricing remains constant in terms of certain parameters such as emergency or elective surgery, accompanying diseases, newborn birth weight, and length of stay in cases involving procedures and operations used in the diagnosis and treatment of cardiovascular diseases.

Anahtar Kelimeler: